BNP Paribas Financial Markets’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18K Sell
992
-344
-26% -$409 ﹤0.01% 4311
2025
Q1
$2.71K Sell
1,336
-605
-31% -$1.23K ﹤0.01% 4108
2024
Q4
$11.7K Buy
+1,941
New +$11.7K ﹤0.01% 3978